Additionally, prostate cancer stands as the most prevalent cancer diagnosis among men, with the identification of prostate-specific antigen (PSA) serving as a biomarker for early detection, emphasizing the clinical significance of recognizing molecular markers like TMEM16A in cancer diagnosis. The gene discussed is ANO1; the disease is prostate cancer.